# Ranibizumab in Diabetic Vitrectomy. A Prospective, Randomised Controlled Trial of Ranibizumab Pre-treatment in Diabetic Vitrectomy - a Pilot Study

> **NCT01306981** · PHASE4 · COMPLETED · sponsor: **Moorfields Eye Hospital NHS Foundation Trust** · enrollment: 30 (actual)

## Conditions studied

- Diabetic Retinopathy
- Retinal Neovascularisation

## Interventions

- **DRUG:** Ranibizumab
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT01306981
- **Lead sponsor:** Moorfields Eye Hospital NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03-30
- **Primary completion:** 2013-03
- **Final completion:** 2013-03-12
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2020-09-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01306981

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01306981, "Ranibizumab in Diabetic Vitrectomy. A Prospective, Randomised Controlled Trial of Ranibizumab Pre-treatment in Diabetic Vitrectomy - a Pilot Study". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01306981. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*